Filter
818
Text search:
drug
prices
Featured
Recommendations
74
New Publications
247
Language
Document type
No document type
486
Studies & Reports
171
Guidelines
77
Strategic & Response Plan
36
Manuals
21
Situation Updates
8
Fact sheets
8
Training Material
4
Resource Platforms
3
Infographics
3
Brochures
1
Countries / Regions
Global
36
India
30
Kenya
28
Uganda
21
Myanmar / Burma
20
Western and Central Europe
17
Liberia
15
Nepal
15
Malawi
15
Zambia
14
South Africa
14
Ukraine
12
Sierra Leone
11
Nigeria
11
Ghana
11
Tanzania
11
Bangladesh
11
Latin America and the Carribbean
11
Zimbabwe
9
Africa
9
Ethiopia
8
Philippines
8
Syria
8
Indonesia
8
Namibia
8
Congo, Democratic Republic of
7
Botswana
7
South–East Asia Region
7
Cameroon
6
Mozambique
6
Asia
6
Eastern Europe
6
Rwanda
5
Senegal
4
Haiti
4
Cambodia
4
Burkina Faso
3
Eswatini/ Swaziland
3
Lesotho
3
Venezuela
3
Tajikistan
3
Guinea
2
Pakistan
2
Jordan
2
North Macedonia
2
Middle East and North Africa
2
Paraguay
2
Albania
2
Russia
2
Moldova
2
Kyrgyzstan
2
Georgia
2
USA
1
South Sudan
1
Afghanistan
1
Germany
1
Lebanon
1
Thailand
1
China
1
Sudan
1
Benin
1
Central African Republic
1
Switzerland
1
Serbia
1
Colombia
1
Bolivia
1
Libya
1
Sri Lanka
1
Eastern Europe and Central Asia
1
Bhutan
1
North Korea
1
Armenia
1
Mongolia
1
Southern Africa
1
Laos
1
Timor Leste/ East Timor
1
Bulgaria
1
Estonia
1
Uzbekistan
1
Kazakhstan
1
Vietnam
1
Gabon
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
316
Clinical Guidelines
80
Public Health
44
Pharmacy & Technologies
20
Key Resources
19
Women & Child Health
18
Capacity Building
4
Toolboxes
HIV
108
Mental Health
79
Pharmacy
56
TB
47
AMR
47
COVID-19
31
NCDs
19
Global Health Education
17
Health Financing Toolbox
17
Conflict
12
NTDs
11
Planetary Health
9
Malaria
9
Ebola & Marburg
8
Refugee
8
Disability
7
Caregiver
6
Polio
4
Natural Hazards
3
Rapid Response
3
Cholera
2
2.0 Rapid Response
1
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial
...
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis.
If no action is taken - warns the UN Ad hoc Interagency Coordin
...
Available in English, French, Spanish, Russian, Chinese, Arabic and Portugues
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner
...
Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related harm? Is advice on ways to reduce drug related harm safe and effective, using an outreach mode
...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Stop TB`s GDF provides a wide range of diagnostic equipment and laboratory supplies in its Diagnostics Catalog
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
Accessed: 28.03.2019
World Drug Report 2017
-1-
Accessed: 14.03.2019
Perspectives on Drugs
A summary of the national drug situation